MASSCODE
Dead / Cancelled — Cancelled — Section 8 (as of 05 Apr 2024)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 75582509
- Registration number
- 2767005
- Mark type
- Word mark
- Filed
- 04 Nov 1998
- Published for opposition
- 16 Apr 2002
- Registered
- 23 Sept 2003
- Next maintenance due
- 23 Sept 2013
- Attorney of record
- Scott S. Havlick
Goods and services
- Class 001 — Chemicals: Chemical compounds, chemical products, and chiral compounds, namely, [ synthons, ] polymerase-based extension assays, [ single nucleotide extension assays, mutation assays, epigenetic assays, Mendelian assays, HPLC assays, dHPLC assays, homology assays, diagnostic assays, RFLP assays, oligonucleotide ligation assays, exonuclease assays, sequencing assays and reactions, genotyping assays, SNP discovery reagents, indexing assays, gene expression assays, ] nucleic acid analysis [, and nucleic acid sizing, ] for scientific and research use
- Class 005 — Pharmaceuticals: [ Chemical compounds, chemical products, and chiral compounds, namely, synthons, polymerase-based extension assays, single nucleotide extension assays, mutation assays, epigenetic assays, Mendelian assays, HPLC assays, dHPLC assays, homology assays, diagnostic assays, RFLP assays, oligonucleotide ligation assays, exonuclease assays, sequencing assays and reactions, genotyping assays, SNP discovery reagents, indexing assays, gene expression assays, nucleic acid analysis, and nucleic acid sizing, for medical and therapeutic use ]
- Class 040 — Treatment of materials: [ MANUFACTURE OF BIOCHEMICALS TO THE ORDER AND SPECIFICATION OF OTHERS AND CONSULTANCY AND ADVISORY SERVICES RELATING THERETO ]
- Class 042 — Scientific and technological services: [ Pharmaceutical research and development services, namely, research and development of pharmaceutical prototypes and consultancy and advisory services relating thereto ]
Owner
- AGILENT TECHNOLOGIES, INC., SANTA CLARA, CA, US
- OPERON BIOTECHNOLOGIES, INC., HUNTSVILLE, AL, US
- QIAGEN NORTH AMERICAN HOLDINGS, INC., ALAMEDA, CA, US
- QIAGEN GENOMICS, INC., Bothell, WA, US
- QIAGEN GENOMICS, INC., Bothell, WA, US
- QIAGEN GENOMICS, INC., Bothell, WA, US
- Rapigene, Inc., Bothell, WA, US
Prosecution history
- 05 Apr 2024 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 23 Sept 2022 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 30 Aug 2013 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 30 Aug 2013 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 30 Aug 2013 — REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
- 30 Aug 2013 — REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
- 17 Aug 2013 — REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
- 30 Aug 2013 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 17 Aug 2013 — TEAS SECTION 8 & 9 RECEIVED
- 16 Nov 2010 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 16 Nov 2010 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 31 Mar 2010 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 02 Feb 2010 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 02 Feb 2010 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 07 Oct 2009 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.